1 Aogi K, "Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer" 150 : 209-217, 2015
2 Witkiewicz AK, "Using the"reverse Warburg effect"to identify high-risk breast cancer patients : stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers" 11 : 1108-1117, 2012
3 Vander Heiden MG, "Understanding theWarburg effect : the metabolic requirements of cell proliferation" 324 : 1029-1033, 2009
4 Sotgia F, "Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment" 13 : 213-, 2011
5 Fu Y, "The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy" 8 : 57813-57825, 2017
6 Pavlides S, "The reverse Warburg effect : aerobic glycolysis in cancer associated fibroblasts and the tumor stroma" 8 : 3984-4001, 2009
7 Ullah MS, "The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism" 281 : 9030-9037, 2006
8 Warburg O, "The metabolism of carcinoma cells" 9 : 148-163, 1925
9 Eheman CR, "The changing incidence of in situ and invasive ductal and lobular breast carcinomas : United States, 1999-2004" 18 : 1763-1769, 2009
10 Sonveaux P, "Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice" 118 : 3930-3942, 2008
1 Aogi K, "Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer" 150 : 209-217, 2015
2 Witkiewicz AK, "Using the"reverse Warburg effect"to identify high-risk breast cancer patients : stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers" 11 : 1108-1117, 2012
3 Vander Heiden MG, "Understanding theWarburg effect : the metabolic requirements of cell proliferation" 324 : 1029-1033, 2009
4 Sotgia F, "Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment" 13 : 213-, 2011
5 Fu Y, "The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy" 8 : 57813-57825, 2017
6 Pavlides S, "The reverse Warburg effect : aerobic glycolysis in cancer associated fibroblasts and the tumor stroma" 8 : 3984-4001, 2009
7 Ullah MS, "The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism" 281 : 9030-9037, 2006
8 Warburg O, "The metabolism of carcinoma cells" 9 : 148-163, 1925
9 Eheman CR, "The changing incidence of in situ and invasive ductal and lobular breast carcinomas : United States, 1999-2004" 18 : 1763-1769, 2009
10 Sonveaux P, "Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice" 118 : 3930-3942, 2008
11 Doherty JR, "Targeting lactate metabolism for cancer therapeutics" 123 : 3685-3692, 2013
12 Kadoya T, "Role ofmaximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer : a multiinstitute study" 141 : 269-275, 2013
13 Grover-McKay M, "Role for glucose transporter 1 protein in human breast cancer" 4 : 115-120, 1998
14 Bovenzi CD, "Prognostic indications of elevated MCT4 and CD147 across cancer types : a meta-analysis" 2015 : 242437-, 2015
15 Groheux D, "Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer" 42 : 377-385, 2015
16 Caroline Kampf, "Production of Tissue Microarrays, Immunohistochemistry Staining and Digitalization Within the Human Protein Atlas" MyJove Corporation (63) : 2012
17 Martinez-Outschoorn UE, "Power surge : supporting cells"fuel"cancer cell mitochondria" 15 : 4-5, 2012
18 Warburg O, "On the origin of cancer cells" 123 : 309-314, 1956
19 Wurm CA, "Nanoscale distribution of mitochondrial import receptor Tom20 is adjusted to cellular conditions and exhibits an innercellular gradient" 108 : 13546-13551, 2011
20 García Vicente AM, "Molecular subtypes of breast cancer : metabolic correlation with 18F-FDG PET/CT" 40 : 1304-1311, 2013
21 Koit A, "Mitochondrial respiration in human colorectal and breast cancer clinical material is regulated differently" 2017 : 1372640-, 2017
22 Porporato PE, "Mitochondrial metabolism and cancer" 28 : 265-280, 2018
23 Sotgia F, "Mitochondria"fuel"breast cancer metabolism : fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells" 11 : 4390-4401, 2012
24 Bellance N, "Mitochondria : from bioenergetics to the metabolic regulation of carcinogenesis" 14 : 4015-4034, 2009
25 Caro P, "Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma" 22 : 547-560, 2012
26 Hensley CT, "Metabolic heterogeneity in human lung tumors" 164 : 681-694, 2016
27 Kaambre T, "Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer" 44 : 539-558, 2012
28 Lester SC, "Members of the Cancer Committee, College of American Pathologies. Protocol for the examination of specimens from patients with invasive carcinoma of the breast" 133 : 1515-1538, 2009
29 Johnson JM, "MCT1 in invasive ductal carcinoma : monocarboxylate metabolism and aggressive breast cancer" 5 : 27-, 2017
30 Whitaker-Menezes D, "Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ : visualizing the therapeutic effects ofmetformin in tumor tissue" 10 : 4047-4064, 2011
31 Huebbers CU, "High glucose uptake unexpectedly is accompanied by high levels of themitochondrial ß-F1-ATPase subunit in head and neck squamous cell carcinoma" 6 : 36172-36184, 2015
32 DeBerardinis RJ, "Fundamentals of cancer metabolism" 2 : e1600200-, 2016
33 Whitaker-Menezes D, "Evidence for a stromalepithelial"lactate shuttle"in human tumors : MCT4 is a marker of oxidative stress in cancer-associated fibroblasts" 10 : 1772-1783, 2011
34 Jeong YJ, "Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT" 20 : 32-38, 2017
35 Ekmekcioglu O, "Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma" 34 : 1055-1067, 2013
36 Ueda S, "Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging(18F-FDG PET/CT)in primary breast cancer" 38 : 250-258, 2008
37 DeNicola GM, "Cancer’s fuel choice : new flavors for a picky eater" 60 : 514-523, 2015
38 Siegel RL, "Cancer statistics, 2019" 69 : 7-34, 2019
39 Curry JM, "Cancer metabolism, stemness and tumor recurrence : MCT1 andMCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer" 12 : 1371-1384, 2013
40 Danhier P, "Cancer metabolism in space and time : beyond the Warburg effect" 1858 : 556-572, 2017
41 Martinez-Outschoorn UE, "Cancer cells metabolically"fertilize"the tumor microenvironment with hydrogen peroxide, driving the Warburg effect : implications for PET imaging of human tumors" 10 : 2504-2520, 2011
42 García Vicente AM, "Basal 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer" 42 : 1804-1813, 2015
43 Fang S, "Advances in glucose metabolism research in colorectal cancer" 5 : 289-295, 2016
44 Caresia Aroztegui AP, "18F-FDG PET/CT in breast cancer : evidence-based recommendations in initial staging" 39 : 1010428317728285-, 2017